These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 15375376)
1. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference. Stege A; Priebsch A; Nieth C; Lage H Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376 [TBL] [Abstract][Full Text] [Related]
2. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes. Kaszubiak A; Holm PS; Lage H Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700 [TBL] [Abstract][Full Text] [Related]
3. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189 [TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441 [TBL] [Abstract][Full Text] [Related]
5. Overcoming multidrug resistance by RNA interference. Stege A; Krühn A; Lage H Methods Mol Biol; 2010; 596():447-65. PubMed ID: 19949936 [TBL] [Abstract][Full Text] [Related]
6. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1. Kaszubiak A; Kupstat A; Müller U; Hausmann R; Holm PS; Lage H Biochem Biophys Res Commun; 2007 May; 357(1):295-301. PubMed ID: 17418094 [TBL] [Abstract][Full Text] [Related]
7. The reversion effect of the RNAi-silencing mdr1 gene on multidrug resistance of the leukemia cell HT9. Shao SL; Sun YY; Li XY; Zhang WW; Fu B; Yun DZ; Zuo MX Cell Biol Int; 2008 Aug; 32(8):893-8. PubMed ID: 18499486 [TBL] [Abstract][Full Text] [Related]
8. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics. Kobayashi H; Takemura Y; Miyachi H Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737 [TBL] [Abstract][Full Text] [Related]
9. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341 [TBL] [Abstract][Full Text] [Related]
10. Jet-injection of short hairpin RNA-encoding vectors into tumor cells. Walther W; Stein U; Lage H Methods Mol Biol; 2010; 629():123-39. PubMed ID: 20387147 [TBL] [Abstract][Full Text] [Related]
11. Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA. Stein U; Walther W; Stege A; Kaszubiak A; Fichtner I; Lage H Mol Ther; 2008 Jan; 16(1):178-86. PubMed ID: 17878902 [TBL] [Abstract][Full Text] [Related]
12. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598 [TBL] [Abstract][Full Text] [Related]
13. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line. Bhat UG; Winter MA; Pearce HL; Beck WT Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells. Zhong X; Safa AR Biochemistry; 2007 May; 46(19):5766-75. PubMed ID: 17441731 [TBL] [Abstract][Full Text] [Related]
15. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells. Peng Z; Xiao Z; Wang Y; Liu P; Cai Y; Lu S; Feng W; Han ZC Cancer Gene Ther; 2004 Nov; 11(11):707-12. PubMed ID: 15375375 [TBL] [Abstract][Full Text] [Related]
16. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188 [TBL] [Abstract][Full Text] [Related]
17. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells. Wang G; Rong J; Zhou Z; Duo J Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809 [TBL] [Abstract][Full Text] [Related]
18. In vivo reversal of P-glycoprotein-mediated multidrug resistance by efficient delivery of stealth RNAi. Xiao H; Wu Z; Shen H; Luo AL; Yang YF; Li XB; Zhu DY Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):342-8. PubMed ID: 18834355 [TBL] [Abstract][Full Text] [Related]
19. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716 [TBL] [Abstract][Full Text] [Related]
20. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA. Li L; Xu J; Min T; Huang W Eur J Pharmacol; 2006 Apr; 536(1-2):93-7. PubMed ID: 16564522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]